FDA/CDC
Latest News
Eighty percent of U.S. maternal deaths are preventable: Study
“It’s significant. It’s staggering. It’s heartbreaking.”
FDA/CDC
FDA approves ‘rapid-acting’ oral drug for major depression
It is the "first and only rapid-acting oral medicine approved for the treatment of MDD.
FDA/CDC
FDA panel rejects pimavanserin for Alzheimer’s psychosis
The FDA will make its final decision by August 4.
FDA/CDC
FDA requires disclosure of suicide risk for anti-baldness drug
The agency has previously approved revised Propecia labels that mentioned risks of persistent sexual dysfunction and depression but not suicide....
FDA/CDC
FDA panel strongly backs protein-based Novavax COVID-19 vaccine
“Having a protein-based alternative may be more comfortable for some in terms of their acceptance of vaccines.”
FDA/CDC
FDA denies petition to disqualify researchers over controversial ketamine studies
“The FDA denied our petition, and we think that sends the wrong signal to the research community.”
FDA/CDC
Many Americans missing an opportunity to prevent dementia
“Health care professionals should also screen patients for modifiable risk factors, counsel patients with risk factors, and refer them to...
FDA/CDC
FDA clears diagnostic test for early Alzheimer’s
“There is a new option that can typically be completed the same day and can give doctors the same information regarding brain amyloid status,...
FDA/CDC
FDA okays first sublingual med for agitation in serious mental illness
With a demonstrated onset of action as early as 20 minutes, dexmedetomidine shows a high response rate in patients at both 120-mcg and 180-mcg...
FDA/CDC
FDA clears once-weekly transdermal patch for Alzheimer’s
Adlarity is the first and only once-weekly patch to continuously deliver consistent doses of the acetylcholinesterase inhibitor through the skin...
News from the FDA/CDC
Clozapine interrupted: APA, others seek FDA forum on REMS
Clozapine can decrease the neutrophil count, which can lead to severe neutropenia, serious infection, and death.